University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review
University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
University of Texas MD Anderson Cancer Center (MD Anderson) is a leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson offers cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its major departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; among others. MD Anderson is headquartered in Houston, Texas, the US.
University of Texas MD Anderson Cancer Center Key Recent Developments
Aug 19,2021: CPRIT awards nearly $13 million in support of MD Anderson research
Aug 05,2021: University of Texas MD Anderson Cancer Center: Researchers discover new factor in preventing phenylketonuria, offering new treatment strategy
Jun 17,2021: Engineered NK cells can eliminate glioblastoma stem cells
May 25,2021: Baptist MD Anderson Cancer Center achieves four-year accreditation for radiation oncology services from ASTRO’s APEx - Accreditation Program for Excellence
May 20,2021: New AI-based tool can find rare cell populations in large single-cell datasets
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
University of Texas MD Anderson Cancer Center (MD Anderson) is a leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson offers cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its major departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; among others. MD Anderson is headquartered in Houston, Texas, the US.
University of Texas MD Anderson Cancer Center Key Recent Developments
Aug 19,2021: CPRIT awards nearly $13 million in support of MD Anderson research
Aug 05,2021: University of Texas MD Anderson Cancer Center: Researchers discover new factor in preventing phenylketonuria, offering new treatment strategy
Jun 17,2021: Engineered NK cells can eliminate glioblastoma stem cells
May 25,2021: Baptist MD Anderson Cancer Center achieves four-year accreditation for radiation oncology services from ASTRO’s APEx - Accreditation Program for Excellence
May 20,2021: New AI-based tool can find rare cell populations in large single-cell datasets
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
SECTION 1 - ABOUT THE COMPANY
University of Texas MD Anderson Cancer Center - Key Facts
University of Texas MD Anderson Cancer Center - Key Employees
University of Texas MD Anderson Cancer Center - Key Employee Biographies
University of Texas MD Anderson Cancer Center - Major Products and Services
University of Texas MD Anderson Cancer Center - History
University of Texas MD Anderson Cancer Center - Company Statement
University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
University of Texas MD Anderson Cancer Center - Business Description
Business Segment: Auxillary Income
Performance
Business Segment: Investment and Other Non-operating Income
Performance
Business Segment: Net Patient Revenue
Performance
Business Segment: Other Income
Performance
Business Segment: Restricted Grants and Contracts, Philanthropy
Performance
Business Segment: State-appropriated General Revenue
Performance
R&D Overview
University of Texas MD Anderson Cancer Center - Corporate Strategy
University of Texas MD Anderson Cancer Center - SWOT Analysis
SWOT Analysis - Overview
University of Texas MD Anderson Cancer Center - Strengths
University of Texas MD Anderson Cancer Center - Weaknesses
University of Texas MD Anderson Cancer Center - Opportunities
University of Texas MD Anderson Cancer Center - Threats
University of Texas MD Anderson Cancer Center - Key Competitors
University of Texas MD Anderson Cancer Center, Recent Deals Summary
SECTION 3 – COMPANY’S RECENT DEVELOPMENTS
Aug 19, 2021: CPRIT awards nearly $13 million in support of MD Anderson research
Aug 05, 2021: University of Texas MD Anderson Cancer Center: Researchers discover new factor in preventing phenylketonuria, offering new treatment strategy
Jun 17, 2021: Engineered NK cells can eliminate glioblastoma stem cells
May 25, 2021: Baptist MD Anderson Cancer Center achieves four-year accreditation for radiation oncology services from ASTRO’s APEx - Accreditation Program for Excellence
May 20, 2021: New AI-based tool can find rare cell populations in large single-cell datasets
May 12, 2021: Mitochondrial enzyme found to block cell death pathway points to new cancer treatment strategy
May 11, 2021: MD Anderson and Broad Institute launch new translational research platform focused on rare cancers
Apr 14, 2021: Boehringer Ingelheim and MD Anderson expand collaboration to accelerate development of KRAS and TRAILR2 compounds in lung cancer
Apr 10, 2021: University of Texas MD Anderson Cancer Center: Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
Mar 10, 2021: VIB spin-off Orionis announces new research collaboration to advance novel small-molecule cancer medicines
SECTION 4 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
University of Texas MD Anderson Cancer Center - Key Facts
University of Texas MD Anderson Cancer Center - Key Employees
University of Texas MD Anderson Cancer Center - Key Employee Biographies
University of Texas MD Anderson Cancer Center - Major Products and Services
University of Texas MD Anderson Cancer Center - History
University of Texas MD Anderson Cancer Center - Company Statement
University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
University of Texas MD Anderson Cancer Center - Business Description
Business Segment: Auxillary Income
Performance
Business Segment: Investment and Other Non-operating Income
Performance
Business Segment: Net Patient Revenue
Performance
Business Segment: Other Income
Performance
Business Segment: Restricted Grants and Contracts, Philanthropy
Performance
Business Segment: State-appropriated General Revenue
Performance
R&D Overview
University of Texas MD Anderson Cancer Center - Corporate Strategy
University of Texas MD Anderson Cancer Center - SWOT Analysis
SWOT Analysis - Overview
University of Texas MD Anderson Cancer Center - Strengths
University of Texas MD Anderson Cancer Center - Weaknesses
University of Texas MD Anderson Cancer Center - Opportunities
University of Texas MD Anderson Cancer Center - Threats
University of Texas MD Anderson Cancer Center - Key Competitors
University of Texas MD Anderson Cancer Center, Recent Deals Summary
SECTION 3 – COMPANY’S RECENT DEVELOPMENTS
Aug 19, 2021: CPRIT awards nearly $13 million in support of MD Anderson research
Aug 05, 2021: University of Texas MD Anderson Cancer Center: Researchers discover new factor in preventing phenylketonuria, offering new treatment strategy
Jun 17, 2021: Engineered NK cells can eliminate glioblastoma stem cells
May 25, 2021: Baptist MD Anderson Cancer Center achieves four-year accreditation for radiation oncology services from ASTRO’s APEx - Accreditation Program for Excellence
May 20, 2021: New AI-based tool can find rare cell populations in large single-cell datasets
May 12, 2021: Mitochondrial enzyme found to block cell death pathway points to new cancer treatment strategy
May 11, 2021: MD Anderson and Broad Institute launch new translational research platform focused on rare cancers
Apr 14, 2021: Boehringer Ingelheim and MD Anderson expand collaboration to accelerate development of KRAS and TRAILR2 compounds in lung cancer
Apr 10, 2021: University of Texas MD Anderson Cancer Center: Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
Mar 10, 2021: VIB spin-off Orionis announces new research collaboration to advance novel small-molecule cancer medicines
SECTION 4 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
University of Texas MD Anderson Cancer Center, Key Facts
University of Texas MD Anderson Cancer Center, Key Employees
University of Texas MD Anderson Cancer Center, Key Employee Biographies
University of Texas MD Anderson Cancer Center, Major Products and Services
University of Texas MD Anderson Cancer Center, History
University of Texas MD Anderson Cancer Center, Other Locations
University of Texas MD Anderson Cancer Center, Subsidiaries
University of Texas MD Anderson Cancer Center, Joint Venture
University of Texas MD Anderson Cancer Center, Key Competitors
University of Texas MD Anderson Cancer Center, Recent Deals Summary
University of Texas MD Anderson Cancer Center, Key Facts
University of Texas MD Anderson Cancer Center, Key Employees
University of Texas MD Anderson Cancer Center, Key Employee Biographies
University of Texas MD Anderson Cancer Center, Major Products and Services
University of Texas MD Anderson Cancer Center, History
University of Texas MD Anderson Cancer Center, Other Locations
University of Texas MD Anderson Cancer Center, Subsidiaries
University of Texas MD Anderson Cancer Center, Joint Venture
University of Texas MD Anderson Cancer Center, Key Competitors
University of Texas MD Anderson Cancer Center, Recent Deals Summary
